We are pleased to confirm our next Leadership Series webinar will take place on the…
marknorm19th September 2020
News & Events
We are organizing another interesting "Lunch and Dialogue" event...this one virtual. We are excited to…
marknorm19th July 2020
One of the most important and critical assessment recruiters have to carry out in their…
marknorm13th July 2020
An authoritative study published in 2017 and supported by Massachusetts Biotechnology Council and Liftstream sheds…
marknorm6th July 2020
When the time comes to recruit, often rushed and seen as a necessary evil, Job…
marknorm29th June 2020
Across the healthcare industry, there are varied companies ensuing an array of new creative ways…
marknorm22nd June 2020
As we have moved from being surprised, sometimes in denial of what happened, to finally…
marknorm15th June 2020
As the new decade begins, artificial intelligence is becoming a reality. There have been major…
marknorm1st February 2020
News
PharmaTimes: News RSS
- Laevoroc announces promising purine nucleoside phosphorylase data 8th December 2022Data supports LR 09 as a vital checkpoint inhibitor for treating leukaemia patients
- ONWARD reveals ARC therapy spinal cord injury report 8th December 2022Implantable ARC therapy demonstrates potential to improve blood pressure regulation
- AstraZeneca focuses on breast cancer care transformation 7th December 2022Data reinforces potential to deliver new standards across HER2-targetable breast cancer
- Odimma Therapeutics and Touchlight announce clinical material collaboration 7th December 2022Partnership aims to progress personalised cancer therapy by incorporating doggybone DNA
- LEO Pharma reveal positive results from delgocitinib research 6th December 2022Phase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema